We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+27.62%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$1.02B
AUM Growth
+$268M
Cap. Flow
+$26.2M
Cap. Flow %
2.58%
Top 10 Hldgs %
33.11%
Holding
117
New
41
Increased
22
Reduced
19
Closed
29

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$17.4M
2
MRK icon
Merck
MRK
+$14.1M
3
NET icon
Cloudflare
NET
+$13.1M
4
FCX icon
Freeport-McMoran
FCX
+$12.9M
5
NVO
Novo Nordisk
NVO
+$12M

Sector Composition

Rank Sector Weight
1 Healthcare 32.83%
2 Technology 25.25%
3 Industrials 9.81%
4 Consumer Discretionary 7.9%
5 Materials 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CALX icon
101
Calix
CALX
$2.39B
-115,000
Closed -$5.02M
CYTK icon
102
CALL
Cytokinetics
CYTK
$10.4B
-497
Closed -$4.15M
DBRG icon
103
DigitalBridge
DBRG
$2.95B
-183,000
Closed -$3.21M
FIVN icon
104
CALL
FIVE9
FIVN
$2.54B
-1,815
Closed -$14.3M
FWONK icon
105
Liberty Media Series C
FWONK
$25.8B
-220,000
Closed -$13.9M
KBR icon
106
KBR
KBR
$4.8B
-114,000
Closed -$6.32M
MYRG icon
107
MYR Group
MYRG
$5.25B
-35,000
Closed -$5.06M
PACB icon
108
Pacific Biosciences
PACB
$368M
-690,000
Closed -$6.77M
PDD icon
109
Pinduoduo
PDD
$131B
-80,000
Closed -$11.7M
POOL icon
110
Pool Corp
POOL
$7.5B
-19,500
Closed -$7.77M
ROIV icon
111
CALL
Roivant Sciences
ROIV
$26.2B
-3,000
Closed -$3.37M
SNDX icon
112
Syndax Pharmaceuticals
SNDX
$1.82B
-40,000
Closed -$864K
SPHR icon
113
Sphere Entertainment
SPHR
$5.73B
-175,875
Closed -$7.05M
VRDN icon
114
Viridian Therapeutics
VRDN
$2.67B
-39,000
Closed -$849K
DJT icon
115
Trump Media & Technology Group
DJT
$2.83B
-249,499
Closed -$4.37M
CBAY
116
DELISTED
Cymabay Therapeutics
CBAY
-145,000
Closed -$3.42M
KRTX
117
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-20,000
Closed -$6.33M

Similar funds

Atika Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Atika Capital Management held 117 positions worth $1.02B, up 36% from $747M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Atika Capital Management's Q1 2024 filing shows 41 new, 22 increased, 19 reduced and 29 closed positions. Its largest new stake was Merck: 114,000 shares worth $15M. The largest sale was Advanced Micro Devices, an estimated $28.8M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

  • Atika Capital Management's largest Q1 2024 buy was Merck: 114,000 shares worth $15M.
  • Atika Capital Management added most to NVIDIA in Q1 2024, an estimated $17.4M increase.
  • Atika Capital Management's biggest Q1 2024 reduction was Advanced Micro Devices, cutting an estimated $28.8M.
  • Atika Capital Management fully exited Liberty Media Series C in Q1 2024, selling an estimated $13.9M.
  • Atika Capital Management's ten largest holdings make up 33% of its $1.02B portfolio in Q1 2024.
  • Atika Capital Management opened 41 new positions and closed 29 in Q1 2024.
  • Atika Capital Management's portfolio value rose 36% quarter-over-quarter to $1.02B.

Based on Atika Capital Management's 13F filing for Q1 2024, filed 14 May 2024.